EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis

The prevention and management of bleeding and thrombosis in patients with cirrhosis poses several difficult clinical questions. These Clinical Practice Guidelines have been developed to provide practical guidance on debated topics, including current views on haemostasis in liver disease, controversy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hepatology 2022-05, Vol.76 (5), p.1151-1184
Hauptverfasser: Villa, Erica, Bianchini, Marcello, Blasi, Annabel, Denys, Alban, Giannini, Edoardo G., de Gottardi, Andrea, Lisman, Ton, de Raucourt, Emmanuelle, Ripoll, Cristina, Rautou, Pierre-Emmanuel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1184
container_issue 5
container_start_page 1151
container_title Journal of hepatology
container_volume 76
creator Villa, Erica
Bianchini, Marcello
Blasi, Annabel
Denys, Alban
Giannini, Edoardo G.
de Gottardi, Andrea
Lisman, Ton
de Raucourt, Emmanuelle
Ripoll, Cristina
Rautou, Pierre-Emmanuel
description The prevention and management of bleeding and thrombosis in patients with cirrhosis poses several difficult clinical questions. These Clinical Practice Guidelines have been developed to provide practical guidance on debated topics, including current views on haemostasis in liver disease, controversy regarding the need to correct thrombocytopenia and abnormalities in the coagulation system in patients undergoing invasive procedures, and the need for thromboprophylaxis in hospitalised patients with haemostatic abnormalities. Multiple recommendations in this document are based on interventions that the panel feels are not useful, even though widely applied in clinical practice.
doi_str_mv 10.1016/j.jhep.2021.09.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2640994960</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016882782102033X</els_id><sourcerecordid>2695515621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-de560584b710a8011cc3de5a62faaaffa3d89121dcd5050318d9f4328842a76c3</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS1ERbeFP8ABWeLCJenYSby2xKValRZppSIBZ8trT7qOknixnSL-fb1s4cCBk62Z7z2N3iPkLYOaARNXQz3s8VBz4KwGVQM0L8iKCYAKRMteklWBZCX5Wp6Ti5QGKASo9hU5b7oGQAq2Ivnm-uuWbkY_e2tG-iUam71Fert4h2WKiYaZHiI-4px9-ZrZ0cnM5gGnMqGhp7sR0fn54fcq72OYdiH5RH3RmewLlehPn_fU-hj3x9VrctabMeGb5_eSfP90821zV23vbz9vrreVbbnMlcNOQCfb3ZqBkcCYtU2ZGcF7Y0zfm8ZJxThz1nXQQcOkU33bcClbbtbCNpfkw8n3EMOPBVPWk08Wx9HMGJakuWhBqVYJKOj7f9AhLHEu1xVKdR3rBGeF4ifKxpBSxF4fop9M_KUZ6GMnetDHTvSxEw1Kl8SL6N2z9bKb0P2V_CmhAB9PAJYsHj1GnWyJzZZUI9qsXfD_838CP4-dgA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2695515621</pqid></control><display><type>article</type><title>EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Villa, Erica ; Bianchini, Marcello ; Blasi, Annabel ; Denys, Alban ; Giannini, Edoardo G. ; de Gottardi, Andrea ; Lisman, Ton ; de Raucourt, Emmanuelle ; Ripoll, Cristina ; Rautou, Pierre-Emmanuel</creator><creatorcontrib>Villa, Erica ; Bianchini, Marcello ; Blasi, Annabel ; Denys, Alban ; Giannini, Edoardo G. ; de Gottardi, Andrea ; Lisman, Ton ; de Raucourt, Emmanuelle ; Ripoll, Cristina ; Rautou, Pierre-Emmanuel ; European Association for the Study of the Liver</creatorcontrib><description>The prevention and management of bleeding and thrombosis in patients with cirrhosis poses several difficult clinical questions. These Clinical Practice Guidelines have been developed to provide practical guidance on debated topics, including current views on haemostasis in liver disease, controversy regarding the need to correct thrombocytopenia and abnormalities in the coagulation system in patients undergoing invasive procedures, and the need for thromboprophylaxis in hospitalised patients with haemostatic abnormalities. Multiple recommendations in this document are based on interventions that the panel feels are not useful, even though widely applied in clinical practice.</description><identifier>ISSN: 0168-8278</identifier><identifier>ISSN: 1600-0641</identifier><identifier>EISSN: 1600-0641</identifier><identifier>DOI: 10.1016/j.jhep.2021.09.003</identifier><identifier>PMID: 35300861</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Anticoagulants - therapeutic use ; Bleeding ; Cirrhosis ; Clinical practice guidelines ; Hemorrhage - etiology ; Hemorrhage - prevention &amp; control ; Hemostasis ; Humans ; Liver cirrhosis ; Liver Cirrhosis - drug therapy ; Liver diseases ; Patients ; Thrombocytopenia ; Thrombosis ; Thrombosis - etiology ; Thrombosis - prevention &amp; control ; Venous Thromboembolism - drug therapy</subject><ispartof>Journal of hepatology, 2022-05, Vol.76 (5), p.1151-1184</ispartof><rights>2021 European Association for the Study of the Liver</rights><rights>Copyright © 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. May 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-de560584b710a8011cc3de5a62faaaffa3d89121dcd5050318d9f4328842a76c3</citedby><cites>FETCH-LOGICAL-c428t-de560584b710a8011cc3de5a62faaaffa3d89121dcd5050318d9f4328842a76c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S016882782102033X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35300861$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Villa, Erica</creatorcontrib><creatorcontrib>Bianchini, Marcello</creatorcontrib><creatorcontrib>Blasi, Annabel</creatorcontrib><creatorcontrib>Denys, Alban</creatorcontrib><creatorcontrib>Giannini, Edoardo G.</creatorcontrib><creatorcontrib>de Gottardi, Andrea</creatorcontrib><creatorcontrib>Lisman, Ton</creatorcontrib><creatorcontrib>de Raucourt, Emmanuelle</creatorcontrib><creatorcontrib>Ripoll, Cristina</creatorcontrib><creatorcontrib>Rautou, Pierre-Emmanuel</creatorcontrib><creatorcontrib>European Association for the Study of the Liver</creatorcontrib><title>EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis</title><title>Journal of hepatology</title><addtitle>J Hepatol</addtitle><description>The prevention and management of bleeding and thrombosis in patients with cirrhosis poses several difficult clinical questions. These Clinical Practice Guidelines have been developed to provide practical guidance on debated topics, including current views on haemostasis in liver disease, controversy regarding the need to correct thrombocytopenia and abnormalities in the coagulation system in patients undergoing invasive procedures, and the need for thromboprophylaxis in hospitalised patients with haemostatic abnormalities. Multiple recommendations in this document are based on interventions that the panel feels are not useful, even though widely applied in clinical practice.</description><subject>Anticoagulants - therapeutic use</subject><subject>Bleeding</subject><subject>Cirrhosis</subject><subject>Clinical practice guidelines</subject><subject>Hemorrhage - etiology</subject><subject>Hemorrhage - prevention &amp; control</subject><subject>Hemostasis</subject><subject>Humans</subject><subject>Liver cirrhosis</subject><subject>Liver Cirrhosis - drug therapy</subject><subject>Liver diseases</subject><subject>Patients</subject><subject>Thrombocytopenia</subject><subject>Thrombosis</subject><subject>Thrombosis - etiology</subject><subject>Thrombosis - prevention &amp; control</subject><subject>Venous Thromboembolism - drug therapy</subject><issn>0168-8278</issn><issn>1600-0641</issn><issn>1600-0641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFv1DAQhS1ERbeFP8ABWeLCJenYSby2xKValRZppSIBZ8trT7qOknixnSL-fb1s4cCBk62Z7z2N3iPkLYOaARNXQz3s8VBz4KwGVQM0L8iKCYAKRMteklWBZCX5Wp6Ti5QGKASo9hU5b7oGQAq2Ivnm-uuWbkY_e2tG-iUam71Fert4h2WKiYaZHiI-4px9-ZrZ0cnM5gGnMqGhp7sR0fn54fcq72OYdiH5RH3RmewLlehPn_fU-hj3x9VrctabMeGb5_eSfP90821zV23vbz9vrreVbbnMlcNOQCfb3ZqBkcCYtU2ZGcF7Y0zfm8ZJxThz1nXQQcOkU33bcClbbtbCNpfkw8n3EMOPBVPWk08Wx9HMGJakuWhBqVYJKOj7f9AhLHEu1xVKdR3rBGeF4ifKxpBSxF4fop9M_KUZ6GMnetDHTvSxEw1Kl8SL6N2z9bKb0P2V_CmhAB9PAJYsHj1GnWyJzZZUI9qsXfD_838CP4-dgA</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Villa, Erica</creator><creator>Bianchini, Marcello</creator><creator>Blasi, Annabel</creator><creator>Denys, Alban</creator><creator>Giannini, Edoardo G.</creator><creator>de Gottardi, Andrea</creator><creator>Lisman, Ton</creator><creator>de Raucourt, Emmanuelle</creator><creator>Ripoll, Cristina</creator><creator>Rautou, Pierre-Emmanuel</creator><general>Elsevier B.V</general><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>202205</creationdate><title>EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis</title><author>Villa, Erica ; Bianchini, Marcello ; Blasi, Annabel ; Denys, Alban ; Giannini, Edoardo G. ; de Gottardi, Andrea ; Lisman, Ton ; de Raucourt, Emmanuelle ; Ripoll, Cristina ; Rautou, Pierre-Emmanuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-de560584b710a8011cc3de5a62faaaffa3d89121dcd5050318d9f4328842a76c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anticoagulants - therapeutic use</topic><topic>Bleeding</topic><topic>Cirrhosis</topic><topic>Clinical practice guidelines</topic><topic>Hemorrhage - etiology</topic><topic>Hemorrhage - prevention &amp; control</topic><topic>Hemostasis</topic><topic>Humans</topic><topic>Liver cirrhosis</topic><topic>Liver Cirrhosis - drug therapy</topic><topic>Liver diseases</topic><topic>Patients</topic><topic>Thrombocytopenia</topic><topic>Thrombosis</topic><topic>Thrombosis - etiology</topic><topic>Thrombosis - prevention &amp; control</topic><topic>Venous Thromboembolism - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Villa, Erica</creatorcontrib><creatorcontrib>Bianchini, Marcello</creatorcontrib><creatorcontrib>Blasi, Annabel</creatorcontrib><creatorcontrib>Denys, Alban</creatorcontrib><creatorcontrib>Giannini, Edoardo G.</creatorcontrib><creatorcontrib>de Gottardi, Andrea</creatorcontrib><creatorcontrib>Lisman, Ton</creatorcontrib><creatorcontrib>de Raucourt, Emmanuelle</creatorcontrib><creatorcontrib>Ripoll, Cristina</creatorcontrib><creatorcontrib>Rautou, Pierre-Emmanuel</creatorcontrib><creatorcontrib>European Association for the Study of the Liver</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Villa, Erica</au><au>Bianchini, Marcello</au><au>Blasi, Annabel</au><au>Denys, Alban</au><au>Giannini, Edoardo G.</au><au>de Gottardi, Andrea</au><au>Lisman, Ton</au><au>de Raucourt, Emmanuelle</au><au>Ripoll, Cristina</au><au>Rautou, Pierre-Emmanuel</au><aucorp>European Association for the Study of the Liver</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis</atitle><jtitle>Journal of hepatology</jtitle><addtitle>J Hepatol</addtitle><date>2022-05</date><risdate>2022</risdate><volume>76</volume><issue>5</issue><spage>1151</spage><epage>1184</epage><pages>1151-1184</pages><issn>0168-8278</issn><issn>1600-0641</issn><eissn>1600-0641</eissn><abstract>The prevention and management of bleeding and thrombosis in patients with cirrhosis poses several difficult clinical questions. These Clinical Practice Guidelines have been developed to provide practical guidance on debated topics, including current views on haemostasis in liver disease, controversy regarding the need to correct thrombocytopenia and abnormalities in the coagulation system in patients undergoing invasive procedures, and the need for thromboprophylaxis in hospitalised patients with haemostatic abnormalities. Multiple recommendations in this document are based on interventions that the panel feels are not useful, even though widely applied in clinical practice.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>35300861</pmid><doi>10.1016/j.jhep.2021.09.003</doi><tpages>34</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0168-8278
ispartof Journal of hepatology, 2022-05, Vol.76 (5), p.1151-1184
issn 0168-8278
1600-0641
1600-0641
language eng
recordid cdi_proquest_miscellaneous_2640994960
source MEDLINE; Elsevier ScienceDirect Journals
subjects Anticoagulants - therapeutic use
Bleeding
Cirrhosis
Clinical practice guidelines
Hemorrhage - etiology
Hemorrhage - prevention & control
Hemostasis
Humans
Liver cirrhosis
Liver Cirrhosis - drug therapy
Liver diseases
Patients
Thrombocytopenia
Thrombosis
Thrombosis - etiology
Thrombosis - prevention & control
Venous Thromboembolism - drug therapy
title EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T12%3A13%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EASL%20Clinical%20Practice%20Guidelines%20on%20prevention%20and%20management%20of%20bleeding%20and%20thrombosis%20in%20patients%20with%20cirrhosis&rft.jtitle=Journal%20of%20hepatology&rft.au=Villa,%20Erica&rft.aucorp=European%20Association%20for%20the%20Study%20of%20the%20Liver&rft.date=2022-05&rft.volume=76&rft.issue=5&rft.spage=1151&rft.epage=1184&rft.pages=1151-1184&rft.issn=0168-8278&rft.eissn=1600-0641&rft_id=info:doi/10.1016/j.jhep.2021.09.003&rft_dat=%3Cproquest_cross%3E2695515621%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2695515621&rft_id=info:pmid/35300861&rft_els_id=S016882782102033X&rfr_iscdi=true